Could an Opioid Addiction Drug Hold the Key to Treating Stimulant Use Disorder?
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
Targeted educational videos featuring a rural physician's experience with buprenorphine significantly reduced perceived barriers and increased primary care practitioners' intention ...
A retrospective chart review from Vancouver General Hospital found that a novel symptom-inhibited fentanyl induction protocol caused no serious adverse ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine